Capital Performance Advisors »

Peregrine Pharmaceuticals shares owned by Capital Performance Advisors

Quarter-by-quarter ownership of Peregrine Pharmaceuticals (CDMO) shares owned by Capital Performance Advisors from 13F filings

Historical chart of Capital Performance Advisors investment in Peregrine Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Peregrine Pharmaceuticals held by Capital Performance Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Peregrine Pharmaceuticals by Capital Performance Advisors

Quarter filed Position value Share count Share price at filing
2024-09-30 $910 80 11.38

More positions owned by Capital Performance Advisors

Dimensional Etf Trust Us Core Equity 2 (DFAC)
Dimensional Etf Trust Us Targeted Vlu (DFAT)
Dimensional Etf Trust Us Mktwide Value (DFUV)
Dimensional Etf Trust Internatnal Val (DFIV)
Apple (AAPL)
Ishares Tr Core S&p500 Etf (IVV)
Dimensional Etf Trust Us Equity Market (DFUS)
Dimensional Etf Trust Us Small Cap Etf (DFAS)
Microsoft Corporation (MSFT)
American Centy Etf Tr Us Sml Cp Valu (AVUV)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Vanguard Index Fds Total Stk Mkt (VTI)
Vanguard Specialized Funds Div App Etf (VIG)
Dimensional Etf Trust World Ex Us Core (DFAX)
Amazon (AMZN)

View all positions for Capital Performance Advisors

Top funds holding Peregrine Pharmaceuticals

BlackRock
BlackRock
Point72 Asset Management
Vanguard Group
AltraVue Capital
State Street Corporation
Royal Bank of Canada
First Light Asset Management
Palisade Capital Management
Snyder Capital Management
Portolan Capital Management
Geode Capital Management
Emerald Advisers
Citadel Advisors
Harbor Capital Advisors

View all funds holding Peregrine Pharmaceuticals